Class 1. Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis

Diagnostic enigma of pulmonary hypertension: Tale from a series of three patients

Anil Kumar Singhi, Anup Banerji, Nandini Biswas, Soumen DasMedica Super Specialty Hospital. India Medical Journal Armed Forces IndiaMed J Armed Forces Ind 2024; 80 (Suppl 1): S320-S324DOI: 10.1016/j.mjafi.2023.08.003 AbstractPulmonary hypertension (PH) is a complex condition with multiple etiological factors. The ability to identify a potential underlying cause is crucial for accurate diagnosis, patient management, and prognostication. […]

Diagnostic enigma of pulmonary hypertension: Tale from a series of three patients Read More »

Synchrotron-Based Phase-Contrast Micro-CT Combined With Histology to Decipher Differences Between Hereditary and Sporadic Pediatric Pulmonary Veno-Occlusive Disease

Ida Jeremiasen, Niccolò Peruzzi, Elna Lampei, Sofie Meyer, Levent M. Akyürek, Erik Gebre‐Medhin, Ceren Mutgan, Peter Dorfmüller, Lavinia Neubert, Danny Jonigk, Csaba Galambos, Karin Tran‐LundmarkDepartment of Experimental Medical Science and Wallenberg Center for Molecular Medicine Lund University. Skåne University Hospital. Sahlgrenska Academy Hospital. Ludwig Boltzmann Institute for Lung Vascular Research. Universities of Giessen and Marburg

Synchrotron-Based Phase-Contrast Micro-CT Combined With Histology to Decipher Differences Between Hereditary and Sporadic Pediatric Pulmonary Veno-Occlusive Disease Read More »

A case of pulmonary veno-occlusive disease and a new bronchoscopic sign

A. W. Matthews, R. BuchananQueen Alexandra Hospital.United Kingdom Respiratory MedicineRespir Med 1990; 84: 503-505DOI: 10.1016/s0954-6111(08)80117-5 AbstractAbstract Not Available CategoryClass I. Pulmonary Veno-occlusive Disease and Pulmonary Capillary HemangiomatosisSymptoms and Findings Associated with Pulmonary Vascular DiseaseDiagnostic Testing for Pulmonary Vascular Disease. Non-invasive TestingDiagnostic Testing for Pulmonary Vascular Disease. Invasive Testing Age Focus: Adult Pulmonary Vascular Disease Fresh or

A case of pulmonary veno-occlusive disease and a new bronchoscopic sign Read More »

Case report: A finding of PVOD and PAH in first degree relatives suggests shared heritable risk and overlapping features of both pulmonary vascular diseases

Roger Winters, Lindsay M. Forbes, Dunbar Ivy, Carlyne Cool, Bryan D. Park, Peter Hountras, David Badesch, Sue Gu, Edda Spiekerkoetter, Roham Zamanian, Stacey Leier Gluck, Todd M. BullUniversity of Colorado and University of Colorado Children’s Hospital. Stanford University.United States Respirology Case ReportsRespirol Case Rep 2024; 12: DOI: 10.1002/rcr2.70064 AbstractPulmonary veno-occlusive disease (PVOD) is a rare form

Case report: A finding of PVOD and PAH in first degree relatives suggests shared heritable risk and overlapping features of both pulmonary vascular diseases Read More »

GCN2 kinase activation mediates pulmonary vascular remodeling and pulmonary arterial hypertension

Maggie M. Zhu, Jingbo Dai, Zhiyu Dai, Yi Peng, You-Yang ZhaoNorthwestern University Feinberg School of Medicine.United States Journal of Clinical Investigation InsightJCI Insight 2024; DOI: 10.1172/jci.insight.177926 AbstractPulmonary arterial hypertension (PAH) is characterized by progressive increase of pulmonary vascular resistance and remodeling that result in right heart failure. Recessive mutations of EIF2AK4 gene (encoding GCN2, General control

GCN2 kinase activation mediates pulmonary vascular remodeling and pulmonary arterial hypertension Read More »

Pediatric Lung Transplantation for Pulmonary Vascular Diseases: Recent Advances and Challenges

Levent Midyat, Eleanor D. Muise, Gary A. VisnerUniversity of Pittsburgh School of Medicine and Children’s Hospital of Pittsburgh. NYU Grossman School of Medicine and Hassenfeld Children’s Hospital. Harvard Medical School and Boston Children’s Hospital.United states Clinics in Chest MedicineClin Chest Med 2024; 45: 761-769DOI: 10.1016/j.ccm.2024.02.023 AbstractPediatric lung transplantation for pulmonary vascular diseases has seen notable advancements

Pediatric Lung Transplantation for Pulmonary Vascular Diseases: Recent Advances and Challenges Read More »

Primary pulmonary hypertension with obstructive venous lesions

D. B. Brewer, D. R HumphreysUniversity of Birmingham and the General Hospital ,Birmingham.United Kingdom British Heart JournalBrit Heart J 1960; 22: 445-448DOI: 10.1136/hrt.22.3.445 AbstractAbstract Not Available CategoryClass I. Pulmonary Veno-occlusive Disease and Pulmonary Capillary HemangiomatosisPulmonary Vascular Pathology Age Focus: Pediatric Pulmonary Vascular Disease Fresh or Filed Publication: Filed (PHiled). Greater than 1-2 years since publication Article

Primary pulmonary hypertension with obstructive venous lesions Read More »

Chemotherapy-induced pulmonary hypertension: role of alkylating agents

Benoît Ranchoux, Sven Günther, Rozenn Quarck, Marie-Camille Chaumais, Peter Dorfmüller, FabriceAntigny, Sébastien J. Dumas, Nicolas Raymond, Edmund Lau, Laurent Savale, Xavier Jaïs, Olivier Sitbon, Gérald Simonneau, Kurt Stenmark, Sylvia Cohen-Kaminsky, Marc Humbert, David Montani, Frédéric PerrosUniversité Paris-Sud and Hôpital de Bicêtre. Centre Chirurgical Marie Lannelongue. Assistance Publique des Hôpitaux de Paris. KU Leuven. University of

Chemotherapy-induced pulmonary hypertension: role of alkylating agents Read More »

Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4

Ignacio Hernandez-Gonzalez, Jair Tenorio, Julian Palomino-Doza, Amaya Martinez Meñaca, Rafael Morales Ruiz, Mauro Lago-Docampo, Marı´a Valverde Gomez, Javier Gomez Roman, Ana Bele´n Enguita Valls, Carmen Perez-Olivares, Diana Valverde, Joan Gil Carbonell, Elvira Garrido-Lestache Rodrı´guez-Monte, Maria Jesus del Cerro, Pablo Lapunzina, Pilar Escribano-SubiasHospital Universitario Río Hortega. Hospital Universitario La Paz. Centro de Investigación Biomédica en Red

Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4 Read More »

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease

Ayako Chida‑Nagai, Koichi Sagawa, Takao Tsujioka, Takanori Fujimoto, Kota Taniguchi, Osamu Sasaki, Gaku Izumi, Hirokuni Yamazawa, Naoki Masaki, Atsushi Manabe, Atsuhito TakedaHokkaido University. Fukuoka Children’s Hospital. Tohoku University Graduate School of Medicine.Japan Heart and VesselsHeart Vessels 2020; 35: 1307-1315DOI: 10.1007/s00380-020-01604-1 AbstractCongenital heart disease-associated pulmonary arterial hypertension (CHD-PAH) is one of the major complications in patients with CHD. A timely closure of the left-to-right shunt will generally result

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease Read More »

Scroll to Top